Hide Board Information

Show Board Information

Asterias Biotherapeutics, Inc. ASTYV

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/25/2014 6:56:54 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Asterias Biotherapeutics, Inc. (OTCMRKTS: ASTYV) Stock Message Board

1. ASTYV Company Profile

    

2. ASTYV Time & Sales

    

3. ASTYV Recent News

    

4. ASTYV Filings

    

5. ASTYV Financials

    

6. ASTYV Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Asterias Biotherapeutics, Inc. ASTYV

Recent Articles

• VAALCO Energy Enhances Exploration with New Rig Agreement
• Endeavour Mining's Assafou Project: Promising PFS Outcomes
• Endeavour Mining Unveils Promising PFS Findings for Assafou Project
• Bigbank Unveils Convenient New Current Account for Customers
• INVL Technology's Comprehensive Investor Outlook for 2025
• PayPoint plc Progresses with Strategic Share Buyback Program
• Understanding Significant Holdings at Intermediate Capital Group
• Upcoming 2025 Schedule for INVL Baltic Real Estate Announced
• Anoto Group Extends Subscription Period for Rights Issue
• FTI Consulting Expands Expertise with Key Appointments in Construction
• Faraday Future Enhances Manufacturing by Insourcing Seat Production
• Microip's Stock Debut Marks a New Era in Semiconductor Design
• Broadridge Partners with First Abu Dhabi Bank for Growth
• Workday's New AI Innovations Enhance Employee Engagement & Insights
• Syrebo Partners with Quality Production to Boost Rehab Tech
• Allegro NV's Innovative Gel Shows Safety in Joint Therapy Trials
• Exploring the Expanding Handyman Service Market Potential
• Binance and Circle Unite to Boost USDC Usage Globally
• Viva Biotech Expands Global Reach with New Boston Branch
• Revolutionizing Rehab: Syrebo's Robotics Reshape Therapy
• Bayport Management Ltd Strengthens Financial Position with Refinancing
• BW LPG Limited Ex-Dividend Announcement for Shareholders Today
• Leading Spain Programmatic Ad Sellers for Q3 2024 Unveiled
• Santhera's AGAMREE Receives NMPA Approval for DMD Treatment
• Sanofi's New Vaccine Candidate Receives Fast Track Status
• Kerecis Expands Its Innovative Medical Frontiers in Europe
• Exciting New Developments in Pediatric Clinical Trials for Leniolisib
• Coop Pank Thrives With Robust November Financial Results
• Red Eléctrica Embraces Innovation with Dassault's 3DEXPERIENCE
• Red Eléctrica's Innovative Shift with Dassault Systèmes’ 3DEXPERIENCE
• BenevolentAI's Strategic Transformations for Future Success
• CJ 4DPLEX and EVT Join Forces to Elevate Cinema in Australia
• Syrebo's Cutting-Edge Rehabilitation Robots Debut at MEDICA 2024
• HDFN Awareness Initiative Launched in Africa by BSV
• BioVaxys Technology Corp. Reduces Private Placement Unit Pricing
• EcoFlow Launches Innovative Program for Sustainable Lifestyle Advocates
• Boardwalk Pipelines Approves Major Investment in Pipeline Project
• CROSSFIRE Animation Launch on Prime Video: An Exciting Update
• Feintool Partners in Hydrogen Mobility with Major Order in China
• TECNO Collaborates with Universities to Enhance Skin Tone Technology
• Quantum Computing, Inc. Secures $50 Million Through Stock Offerings
• VersiFi Receives Approval for Digital Asset Trading Solutions
• Surgo Health Delivers a Pioneering Tool for Youth Mental Wellbeing
• Exploring the $32 Trillion Market Opportunity for Women-Centric Services
• The Urgent Need for Climate Action to Safeguard Profits
• China Seizes Majority of Global EV Traction Inverter Market
• Nokia and SK Broadband Enhance Security for Energy Infrastructure
• Highlights from the 2024 Global Pitch Competition Finale
• Exciting Developments with the Launch of LF India
• Harmony of Tradition and Modernity: The Artistry of Vincent Fang